Exhibit 107
Calculation of Filing Fee Tables
Form 424(b)(5)
(Form Type)
Chinook Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule (1) |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee | |||||||||
|
Newly Registered Securities | ||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share (2) | Rule 457(r) | 7,553,572 | $14.0000 | $105,750,008 | $0.0000927 | $9,803 | ||||||||
| Equity | Common Stock, $0.0001 par value per share, underlying pre-funded warrants to purchase common stock | Rule 457(r) | 1,071,428 | $13.9999 | $14,999,885 | $0.0000927 | $1,391 | |||||||||
| Equity | Pre-funded Warrants (3) | Rule 457(g) | — | — | — | — | — | |||||||||
| Total Offering Amount | $120,749,892 | $11,194 | ||||||||||||||
| Total Fees Previously Paid | N/A | |||||||||||||||
| Total Fee Offsets | N/A | |||||||||||||||
| Net Fee Due | $11,194 | |||||||||||||||
| (1) | The filing fee is calculated in accordance with Rule 457(r) of the Securities Act of 1933, as amended (the “Securities Act”). Payment of the registration fee at the time of filing of the registrant’s registration statement on Form S-3ASR, filed with the Securities and Exchange Commission on May 24, 2022 (File No. 333-265168) (the “Registration Statement”), was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act. This paragraph shall be deemed to update the “Calculation of Registration Fee” table in the Registration Statement. |
| (2) | Includes 1,125,000 additional shares of common stock that the underwriters have an option to purchase. |
| (3) | No registration fee pursuant to Rule 457(g) under the Securities Act. |